Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127967621 | 12796762 | 1 | I | 20160919 | 20160929 | 20160929 | EXP | IL-FRESENIUS KABI-FK201607197 | FRESENIUS KABI | GIL B,MERAV L,PNINA L,CHAGAI G. DIAGNOSIS AND TREATMENT OF CLINICALLY AMYOPATHIC DERMATOMYOSITIS (CADM): A CASE SERIES AND LITERATURE REVIEW. CLIN RHEUMATOL 2016;35 (8):2125-2130. | 27.00 | YR | M | Y | 0.00000 | 20160929 | OT | IL | IL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127967621 | 12796762 | 1 | PS | METHOTREXATE (Manufacturer Unknown) | METHOTREXATE | 1 | Unknown | U | 40263 | UNKNOWN | |||||||||
| 127967621 | 12796762 | 2 | SS | METHOTREXATE (Manufacturer Unknown) | METHOTREXATE | 1 | U | 40263 | |||||||||||
| 127967621 | 12796762 | 3 | SS | CYCLOPHOSPHAMIDE (Manufacturer unknown) | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | UNKNOWN | |||||||||
| 127967621 | 12796762 | 4 | SS | CYCLOPHOSPHAMIDE (Manufacturer unknown) | CYCLOPHOSPHAMIDE | 1 | U | 0 | |||||||||||
| 127967621 | 12796762 | 5 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | 0 | ||||||||||||
| 127967621 | 12796762 | 6 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | 0 | ||||||||||||
| 127967621 | 12796762 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 127967621 | 12796762 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 127967621 | 12796762 | 9 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 0 | ||||||||||||
| 127967621 | 12796762 | 10 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 0 | ||||||||||||
| 127967621 | 12796762 | 11 | SS | PROSTAGLANDINS | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
| 127967621 | 12796762 | 12 | SS | PROSTAGLANDINS | UNSPECIFIED INGREDIENT | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127967621 | 12796762 | 1 | Dermatomyositis |
| 127967621 | 12796762 | 2 | Raynaud's phenomenon |
| 127967621 | 12796762 | 3 | Dermatomyositis |
| 127967621 | 12796762 | 4 | Raynaud's phenomenon |
| 127967621 | 12796762 | 5 | Dermatomyositis |
| 127967621 | 12796762 | 6 | Raynaud's phenomenon |
| 127967621 | 12796762 | 7 | Dermatomyositis |
| 127967621 | 12796762 | 8 | Raynaud's phenomenon |
| 127967621 | 12796762 | 9 | Dermatomyositis |
| 127967621 | 12796762 | 10 | Raynaud's phenomenon |
| 127967621 | 12796762 | 11 | Dermatomyositis |
| 127967621 | 12796762 | 12 | Raynaud's phenomenon |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127967621 | 12796762 | OT |
| 127967621 | 12796762 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127967621 | 12796762 | Bursitis | |
| 127967621 | 12796762 | Interstitial lung disease | |
| 127967621 | 12796762 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |